0001013594-24-001040.txt : 20241223 0001013594-24-001040.hdr.sgml : 20241223 20241223204814 ACCESSION NUMBER: 0001013594-24-001040 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241212 FILED AS OF DATE: 20241223 DATE AS OF CHANGE: 20241223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SANGSANGIN INVESTMENT & SECURITIES CO., LTD. CENTRAL INDEX KEY: 0002049712 ORGANIZATION NAME: STATE OF INCORPORATION: M5 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39011 FILM NUMBER: 241575427 BUSINESS ADDRESS: STREET 1: 49F, PARC.1, 108, YEOUI-DAERO STREET 2: YEONGDEUNGPO-GU CITY: SEOUL STATE: M5 ZIP: 07335 BUSINESS PHONE: 82-2-1566-0900 MAIL ADDRESS: STREET 1: 49F, PARC.1, 108, YEOUI-DAERO STREET 2: YEONGDEUNGPO-GU CITY: SEOUL STATE: M5 ZIP: 07335 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXICURE, INC. CENTRAL INDEX KEY: 0001698530 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 815333008 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2430 N. HALSTED ST. CITY: CHICAGO STATE: IL ZIP: 60614 BUSINESS PHONE: 847-673-1700 MAIL ADDRESS: STREET 1: 2430 N. HALSTED ST. CITY: CHICAGO STATE: IL ZIP: 60614 FORMER COMPANY: FORMER CONFORMED NAME: Max-1 Acquisition Corp DATE OF NAME CHANGE: 20170221 3 1 form3.xml X0206 3 2024-12-12 0 0001698530 EXICURE, INC. XCUR 0002049712 SANGSANGIN INVESTMENT & SECURITIES CO., LTD. 49F, PARC.1, 108, YEOUI-DAERO YEONGDEUNGPO-GU SEOUL M5 07335 KOREA, REPUBLIC OF true Common Stock 433332 D Sangsangin Co., Ltd., a corporation formed under the laws of the Republic of Korea, as the majority shareholder of the Reporting Person, may be deemed to beneficially own the shares reported by the Reporting Person hereunder. Mr. Junwon Yoo, as the chief executive officer of Sangsangin Co., Ltd., may be deemed to beneficially own the shares beneficially owned by Sangsangin Co., Ltd. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. The filing of this Form 3 shall not be deemed an admission that the Reporting Person is, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owner of any securities of the Issuer it does not directly own. Sangsangin Investment & Securities Co., Ltd. By: /s/ Won Ju Title: Chief Executive Officer 2024-12-23